3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other neoplasm
1
Gynecologic
1
Conditions
Lung Neoplasms
7
Carcinoma, Non-Small-Cell Lung
7
Breast Neoplasms
7
Lymphoma, Large B-Cell, Diffuse
5
Leukemia
5
Ovarian Neoplasms
4
Lymphoma
4
Squamous Cell Carcinoma of Head and Neck
3
Precancerous Conditions
3
Neoplasms, Plasma Cell
3
Myelodysplastic Syndromes
3
Multiple Myeloma
3
Lymphoma, Large-Cell, Anaplastic
3
Immunoblastic Lymphadenopathy
3
Head and Neck Neoplasms
3
Esophageal Neoplasms
3
Central Nervous System Neoplasms
3
Burkitt Lymphoma
3
Adenocarcinoma Of Esophagus
3
Tongue Neoplasms
2
Testicular Germ Cell Tumor
2
Stomach Neoplasms
2
Sarcoma
2
Prostatic Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Osteosarcoma
2
Neuroectodermal Tumors, Primitive, Peripheral
2
Neuroblastoma
2
Neoplasm Metastasis
2
Myeloproliferative Disorders
2
Interventions
Colposcopy
13
Imiquimod
12
Conization
11
Papillomavirus Vaccines
8
Cryotherapy
6
Vaccines
5
Papanicolaou Test
4
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
4
Acetic Acid
4
Watchful Waiting
3
Vaginal Smears
3
Surveys and Questionnaires
3
Biopsy
3
human papillomavirus vaccine, L1 type 16, 18
2
Spectrometry, Fluorescence
2
Proflavine
2
Mass Screening
2
Immunohistochemistry
2
Human Papillomavirus DNA Tests
2
High-Throughput Screening Assays
2
Flow Cytometry
2
Curcumin
2
Blood Specimen Collection
2
pembrolizumab
1
nimotuzumab
1
lime
1
human papillomavirus vaccine, TA
1
hecolin
1
efineptakin alfa
1
Zoledronic Acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Uterine Cervical Dysplasia
×
Microarray Analysis
×
Clear all
NCT00629577
2017-02-01
SAGE
British Columbia Cancer Agency
Phase 1
Terminated
50 enrolled